There are currently 189 clinical trials in Sarasota, Florida looking for participants to engage in research studies. Trials are conducted at various facilities, including Sarasota Memorial Hospital, Florida Cancer Specialists, GSK Investigational Site and Sarasota Retina Institute. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid Tumors
NCT05821777
Recruiting
The purpose of this study is to assess safety, tolerability, and preliminary activity of LB101 monotherapy in participants with advanced solid tumors.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/30/2024
Locations: Sarah Cannon Research Institute at Florida Cancer Specialists, Sarasota, Florida
Conditions: Advanced Solid Tumor
Register for Updates
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
NCT04849728
Recruiting
This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3
Gender:
All
Ages:
18 years and above
Trial Updated:
01/24/2024
Locations: Covenant Metabolic Specialists LLC - Sarasota, Sarasota, Florida
Conditions: NASH - Nonalcoholic Steatohepatitis
Register for Updates
Validating Gulf War Illness Blood Biomarkers
NCT05736146
Recruiting
The investigators goals are to identify blood lipids/metabolites that correlate with cognitive decline in the presence of the APOE ε4 allele among veterans with GWI. To determine the effect of dietary, medical and biological factors that influence lipid and metabolites in blood from GW veterans. To identify blood lipid/metabolite profiles that correlate with bioenergetics deficits and glial activation in the brains of GWI. To validate blood biomarker signatures of GWI using APOE genotyping and b... Read More
Gender:
All
Ages:
35 years and above
Trial Updated:
01/24/2024
Locations: The Roskamp Institute, Sarasota, Florida
Conditions: Gulf War Syndrome, Gulf War Illness
Register for Updates
Symfony vs Vivity in Dim Light
NCT06229106
Recruiting
The purpose of this study is to evaluate the visual outcomes of the Symfony lens and the Vivity lens under mesopic lighting conditions in adult patients undergoing routine cataract surgery. Participants will be asked to read a visual acuity chart at different distances in dim light.
Gender:
All
Ages:
50 years and above
Trial Updated:
01/19/2024
Locations: Center for Sight, Sarasota, Florida
Conditions: Cataract
Register for Updates
The Synergy Disc for the Treatment of 2 Level Cervical Degenerative Disc Disease Compared With Cervical Fusion Surgery
NCT05740176
Recruiting
A multicenter, prospective, non-randomized, historically controlled study. To demonstrate the Synergy Disc is at least as safe and effective as conventional anterior cervical discectomy and fusion (ACDF) to treat cervical degenerative disc disease (DDD) in subjects who are symptomatic at two levels from C3 to C7 are and are unresponsive to conservative management. Patients will be evaluated preoperatively, at the time of surgery, and at 6 weeks, and 3, 6, 12, and 24 months after surgery. Follow-... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/15/2024
Locations: Kennedy-White Orthopaedic Center, Sarasota, Florida
Conditions: Cervical Degenerative Disc Disease
Register for Updates
C-Brace Prospective Registry
NCT04640584
Recruiting
To gather prospective safety and effectiveness data for the C-Brace System following the standard of care.
Gender:
All
Ages:
All
Trial Updated:
01/09/2024
Locations: Hanger - Sarasota, Sarasota, Florida
Conditions: Pareses, Lower Extremity
Register for Updates
A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody
NCT05662397
Recruiting
This is a Phase 1/2 study of HST-1011, a CBL-B inhibitor, being developed for the treatment of patients with advanced solid tumors, who relapsed while on or are refractory to approved anti-PD(L)1 therapies or other standard of care.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/08/2024
Locations: Florida Cancer Specialists, Sarasota, Florida
Conditions: Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer
Register for Updates
CLN-418 Study on Subjects With Advanced Solid Tumors
NCT05306444
Recruiting
Study to evaluate the safety and tolerability of the study drug CLN-418, to determine the maximum tolerated dose and/or recommended Phase 2 study dose of CLN-418.
Gender:
All
Ages:
18 years and above
Trial Updated:
12/12/2023
Locations: Florida Cancer Specialists, Sarasota, Florida
Conditions: Advanced Solid Tumor
Register for Updates
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)
NCT04951219
Recruiting
A 52-Week, Multi-center, Open-label, Active Treatment Extension Study to Evaluate Safety and Tolerability of Once Daily, Oral Administration of Resmetirom (MGL-3196)
Gender:
All
Ages:
18 years and above
Trial Updated:
11/28/2023
Locations: Covenant Research, Sarasota, Florida
Conditions: Non-Alcoholic Fatty Liver Disease
Register for Updates
Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System
NCT05826665
Recruiting
STAR Apollo Mapping System is an FDA cleared mapping technology that can analyze the signals collected during the ablation procedure on the 3D mapping system and give the physician further insight into the AF activation patterns which may assist them in identifying areas responsible for maintaining Atrial Fibrillation (AF). The STAR Apollo Mapping System system allows clinicians, after treating the Pulmonary Veins (PV), to collect data from the atria during clinical AF procedures using standard... Read More
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
10/13/2023
Locations: Sarasota Medical Center, Sarasota, Florida
Conditions: Persistent Atrial Fibrillation
Register for Updates
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)
NCT05117489
Recruiting
This phase 1b, Open-Label Study is to assess the safety, efficacy of miricorilant in patients with presumed Nonalcoholic Steatohepatitis (NASH)
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
09/28/2023
Locations: Site 210, Sarasota, Florida
Conditions: Nonalcoholic Steatohepatitis (NASH)
Register for Updates
ImPACT Normative Extension
NCT03180905
Recruiting
The researchers want to find out more about a standalone software application, ImPACT Online and how it relates to other commonly used tests of memory, attention and reaction time. ImPACT Online is a computer-based neurocognitive test for concussion management. The test was designed to help measure the effects of concussion on cognitive processes (for example, memory, attention, brain speed) and visual functioning.
Gender:
All
Ages:
Between 60 years and 80 years
Trial Updated:
09/27/2023
Locations: Comprehensive Med Psych Systems, Inc., Sarasota, Florida
Conditions: Brain Concussion
Register for Updates